Clinical Trial Update: The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial update evaluating distal protection with the BX Velocity device for coronary artery disease; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BX Velocity Distal Protection System

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED